SKShuhei Kuwabara

Shuhei Kuwabara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shuhei Kuwabara has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Hiro Inoue

    Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, USA

    1 shared publication
  • Jiawei Ma

    Graduate School of Pharmaceutical Sciences Chiba University Chiba Japan

    1 shared publication
  • Junlan Yao

    Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, USA

    1 shared publication
  • Mark D. Okusa

    Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, USA

    1 shared publication
  • Motoyuki Itoh

    Graduate School of Pharmaceutical Sciences Chiba University Chiba Japan

    1 shared publication
  • Rahul Sharma

    Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, USA

    1 shared publication

Latest Publications

  • Open Access

    Notch signaling pathway mediates anti-inflammatory effects of vagus nerve stimulation during lipopolysaccharide-induced acute kidney injury

    by Shuhei Kuwabara, Hiro Inoue, William T. Nash, Junlan Yao, Vikram Sabapathy, Shuqiu Zheng, Rahul Sharma, Ryo Hatano, Takashi Miki, Mark D. Okusa

    The cholinergic anti-inflammatory pathway (CAP) plays a central role in neuroimmunomodulation, and its activation is a potential strategy for ameliorating sepsis-associated acute kidney injury (SA-AKI). However, further investigations are necessary to understand the molecular mechanisms of CAP activation and develop therapies for SA-AKI. Here, we tested whether the Notch signaling pathway, which regulates cell-cell interactions, mediates the anti-inflammatory effects of CAP. Using a mouse model of lipopolysaccharide (LPS)-induced AKI, we found that CAP activation by vagus nerve stimulation (VNS) enhanced Notch2 signaling in macrophages, mitigating inflammation in the spleen and tissue damage in the kidneys. Consistently, macrophage-specific knockout of Notch2 resulted in an attenuation of these anti-inflammatory effects of VNS. We also demonstrated that VNS and macrophage-specific Notch2 signaling might upregulate transferrin, which maintains iron homeostasis, thereby protecting the kidneys. Taken together, our findings suggest the involvement of Notch signaling in the mechanisms of VNS-mediated CAP activation during LPS-induced AKI.

  • Notch signaling pathway suppresses mRNA expression of hexokinase 2 under nutrient‐poor conditions in U87‐MG glioma cells

    by Shuhei Kuwabara, Takamasa Mizoguchi, Jiawei Ma, Tohgo Kanoh, Yuki Ohta, Motoyuki Itoh

    Control of nutrient homeostasis plays a central role in cell proliferation/survival during embryonic development and tumor growth. Activation of the Notch signaling pathway, a major contributor to cell–cell interactions, is a potential mechanism for cell adaptation to nutrient‐poor conditions. Our previous study also demonstrated that during embryogenesis when nutrients such as glutamine and growth factors are potentially maintained at lower levels, Notch signaling suppresses mRNA expression of hexokinase 2 (hk2), which is a glycolysis‐associated gene, in the central nervous system. However, whether and how the genetic regulation of HK2 via Notch signaling contributes to cellular adaptability to nutrient‐poor environments remains unknown. In this study, we performed gene expression analysis using a U87‐MG human glioma cell line and revealed that under conditions where both glutamine and serum were absent, Notch signaling was activated and HK2 expression was downregulated by Notch signaling. We also found that Notch‐mediated HK2 suppression was triggered in a Notch ligand‐selective manner. Furthermore, HK2 was shown to inhibit cell proliferation of U87‐MG gliomas, which might depend on Notch signaling activity. Together, our findings suggest the involvement of Notch‐mediated HK2 suppression in an adaptive mechanism of U87‐MG glioma cells to nutrient‐poor conditions.